Global /China /Healthcare /Drug Manufacturers - General /300086

Honz Pharmaceutical Co., Ltd.

300086

• SHE: 300086 • Delayed

7.40CNY 2.5%

1.09 USD

As of 15 June 2026, Honz Pharmaceutical Co., Ltd. has a market cap of $484.95M USD, ranking #15332 globally and #4792 in China. It ranks #1363 in the Healthcare sector, and #502 in the Drug Manufacturers - General industry.

Global Rank

15332

Country Rank

4792

Sector Rank

1363

Industry Rank

502

Key Stats

Market Cap

$484.95MUSD

3.29B CNY

Enterprise Value

$545.92MUSD

3.69B CNY

Revenue (TTM)

$68.79MUSD

466.12M CNY

EBITDA (TTM)

-$13.77MUSD

-93.17M CNY

Net Income (TTM)

-$33.96MUSD

-230.14M CNY

EBITDA Margin

-20%

Profit Margin

-49%

PS Ratio

7.0

PB Ratio

3.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jiangyou Hong open_in_new

Employees

659

Founded

1993

Website

honz.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.5%	-3%	-14%	-30%	3.7%	-40%	63%	17%	-11%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300086 康芝药业股份有限公司 ISIN: CNE100000QM6 Shares Out.: Shares Outstanding: 455.124M¹ Shares Float: 266.667M² TV: TradingView: SZSE: 300086 SA: Stock Analysis: SHE: 300086 YF: Yahoo Finance: 300086.SZ GF: Google Finance: SHE: 300086 BA: Barron's: 300086 MS: Morningstar: XSHE: 300086	7.40 CNY	TV: TradingView: SZSE: 300086 SA: Stock Analysis: SHE: 300086 YF: Yahoo Finance: 300086.SZ GF: Google Finance: SHE: 300086 BA: Barron's: 300086 MS: Morningstar: XSHE: 300086

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Honz Pharmaceutical Co., Ltd.

Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks. It markets its products through a network of agents and sales terminals. Honz Pharmaceutical Co., Ltd. was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. was founded in 1993 and is based in Guangzhou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 11K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 10K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 6K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 4K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 157K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 113K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 74K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 66K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 59K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 57K%	20.5	Switzerland

chevron_leftBack